Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $158K invested in Sonnet BioTherapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$51.2K | |
| 2 | +$42.9K | |
| 3 | +$3.64K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$181 |
| 5 |
JPMorgan Chase & Co
New York
|
+$33 |
Top Sellers
| 1 | -$10.6K | |
| 2 | -$270 | |
| 3 | -$45 | |
| 4 |
Morgan Stanley
New York
|
-$42 |
| 5 |
Citigroup
New York
|
-$9 |